Shelf-life extension of azacitidine: waste and cost reduction in the treatment of myelodysplastic syndromes

Saved in:
Bibliographic Details
Published in:Leukemia & lymphoma 2015-02, Vol.56 (2), p.542-544
Main Authors: Guirguis, Hany R., Charbonneau, Lauren F., Tyono, Ivan, Wells, Richard A., Cheung, Matthew C., Buckstein, Rena
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic - economics
Antimetabolites, Antineoplastic - therapeutic use
Azacitidine - economics
Azacitidine - therapeutic use
Cost Savings
Cost-Benefit Analysis
Drug Compounding - methods
Drug Costs
Drug Stability
Drug Storage - methods
Female
Freezing
Humans
Male
Medical Waste Disposal - economics
Medical Waste Disposal - statistics & numerical data
Middle Aged
Myelodysplastic Syndromes - drug therapy
Myelodysplastic Syndromes - economics
Outcome Assessment (Health Care) - economics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1042-8194
1029-2403
DOI:10.3109/10428194.2014.927457